Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
7 papers
Recent·Most cited
S. Goel, V. Bhatia, S. Carskadon…·B. Ateeq
The paper identifies a transcriptional network involving ERG, AR, and DLX1 in prostate cancer progression and shows BET inhibitors can target this network.
N. Palanisamy, P. D. Arachchige, S. Carskadon…·S. R. Williamson
The paper evaluates molecular heterogeneity in prostate cancer biopsy samples using dual immunohistochemistry and RNA in situ hybridization, finding clonal differences and higher heterogeneity in African American patients.
D. S. Chandrashekar, B. V. S. K. Chakravarthi, A. D. Robinson…·S. Varambally
This study identifies PAK4 amplification and overexpression in bladder cancer and shows PAK4 inhibition reduces tumor growth, with potential for combination therapy.
B. V. Chakravarthi, P. D. Arachchige, S. Carskadon…·N. Palanisamy
The paper identifies and validates a novel gene fusion in prostate cancer involving KLK4 and KLKP1, showing its association with high Gleason grade tumors and potential as a biomarker.
R. Tiwari, N. Manzar, V. Bhatia…·B. Ateeq
This study shows that androgen deprivation therapy upregulates SPINK1, which enhances cellular plasticity and contributes to poor outcomes in prostate cancer.
V. Bhatia, A. Yadav, R. Tiwari…·B. Ateeq
This study identifies miRNA-338-5p and miRNA-421 as epigenetically silenced in SPINK1-positive prostate cancer, and shows their restoration inhibits oncogenic properties.